Axogen, Inc. — Director's Dealing 2020

Apr 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-04-16

Reporting Person: Zaderej Karen L. (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-16	Common Stock	M	11625	$4.81	Acquired	658869	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-16	Employee Stock Option (right to buy)	$4.81	M	11625	Acquired	2021-01-02	Common Stock (11625)	Direct

Footnotes

F1: This Form is being filed to report the cash exercise of a stock option for a total of 11,625 shares.